Competitive problems in the drug industry : oral hypoglycemic drugs : summary and analysis

LDR 01652cam a2200301I 4500
001 011343923
003 MiAaHDL
005 20110215000000.0
006 m d
007 cr bn ---auaua
008 790119s1978 dcu b f000 0 eng d
035 ⊔ ⊔ ‡asdr-pur1629968
035 ⊔ ⊔ ‡a1629968
035 ⊔ ⊔ ‡a(OCoLC)4566226
040 ⊔ ⊔ ‡aFTC ‡cFTC ‡dIUL
049 ⊔ ⊔ ‡aIPL1
086 0 ⊔ ‡aY 4.SM 1/2:D 84/8
090 ⊔ ⊔ ‡aRM355 ‡b.U5L5
110 2 ⊔ ‡aLibrary of Congress. ‡bCongressional Research Service.
245 1 0 ‡aCompetitive problems in the drug industry : oral hypoglycemic drugs : ‡bsummary and analysis / ‡cprepared by the Congressional Research Service, Library of Congress.
250 ⊔ ⊔ ‡aNovember 30, 1978.
260 ⊔ ⊔ ‡aWashington : ‡bU.S. G.P.O. : ‡b[For sale by the Supt. of Docs., U.S. G.P.O., Congressional Sales Office], ‡c1978.
300 ⊔ ⊔ ‡a112 p. ; ‡c24 cm.
500 ⊔ ⊔ ‡aA summary analysis and discussion of issues highlighted during the 1974-75 hearings on oral hypoglycemic drugs (competitive problems in the drug industry, parts 25 and 28), with a review of current findings and subsequent federal government actions relating to these drugs [prepared by Stephanie Forbes for] the Select Committee on Small Business, United States Senate, Subcommittee on Monopoly and Anticompetitive Activities.
504 ⊔ ⊔ ‡aBibliographical footnotes.
538 ⊔ ⊔ ‡aMode of access: Internet.
650 ⊔ 0 ‡aHypoglycemia.
650 ⊔ 0 ‡aDrugs ‡xPrices.
700 1 ⊔ ‡aForbes, Stephanie.
710 1 ⊔ ‡aUnited States. ‡bCongress. ‡bSenate. ‡bSelect Committee on Small Business. ‡bSubcommittee on Monopoly and Anticompetitive Activities.
740 0 ⊔ ‡aOral hypoglycemic drugs.
CID ⊔ ⊔ ‡a011343923
DAT 0 ⊔ ‡a20101014201840.0 ‡b20110215000000.0
DAT 1 ⊔ ‡a20120815064345.0 ‡b2024-02-07T18:35:37Z
CAT ⊔ ⊔ ‡aSDR-PUR ‡dUNKNOWN ‡lloader.pl-001-001
FMT ⊔ ⊔ ‡aBK
HOL ⊔ ⊔ ‡0sdr-pur1629968 ‡apur1 ‡bSDR ‡cPUR ‡ppur1.32754078065624 ‡sPUR ‡11629968
974 ⊔ ⊔ ‡bPUR ‡cPUR ‡d20240207 ‡sgoogle ‡upur1.32754078065624 ‡y1978 ‡rpd ‡qbib ‡tUS fed doc